Company:  ABBVIE INC. (ABBV)
Form Type:  10-Q
Filing Date:  11/12/2013 
CIK:  0001551152 
Address:  1 NORTH WAUKEGAN ROAD 
City, State, Zip:  NORTH CHICAGO, Illinois 60064 
Telephone:  (847) 932-7900 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$49.32  
Change: 
-0.82 (-1.64%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$78.72B
Description of Business
On January 1, 2013, AbbVie(1) became an independent company as a result of the distribution by Abbott Laboratories (Abbott) of 100 percent of the outstanding common stock of AbbVie to Abbott's shareholders. Each Abbott shareholder of record as of the close of business on December 12, 2012 (the Record Date) received one share of AbbVie common stock for each Abbott common share held as of the Record Date. AbbVie was incorporated in Delaware on April 10, 2012 to hold Abbott's former research-based pharmaceuticals business. AbbVie's common stock began trading "regular-way" under the ticker symbol "ABBV" on the New York Stock Exchange on January 2, 2013. Overview AbbVie is a global, research-based biopharmaceutical company. AbbVie develops and markets advanced therapies that address some of the world's most complex and serious diseases.
Register for EDGAR Pro and access this filing in:     
  FORM 10-Q
    PART I. Financial Information
      Item 1. Financial Statements and Supplementary Data
        INCOME STATEMENT
        CASH FLOW
        BALANCE SHEET
        STOCKHOLDERS EQUITY
        Notes to Condensed Consolidated Financial Statements (unaudited)
          CASH FLOW
          CASH FLOW
      Item 2. Management's Discussion and Analysis of Financial ...
      Item 3. Quantitative and Qualitative Disclosures on Market Risk
      Item 4. Controls and Procedures
    PART II. OTHER INFORMATION
      Item 1. Legal Proceedings
      Item 2. Unregistered Sales of Equity Securities and Use of ...
      Item 6. Exhibits
    SIGNATURE
    EXHIBIT INDEX
    PART I
      FINANCIAL STATEMENTS
        INCOME STATEMENT
  EXHIBIT 31.1
    Certification of Chief Executive Officer
  EXHIBIT 31.2
    Certification of Chief Financial Officer
  EXHIBIT 32.1
    Certification Pursuant To
  EXHIBIT 32.2
    Certification Pursuant To
BROKERAGE PARTNERS